AdvanDx Inc, Woburn, Mass, launched its vanA/B Evigene in Europe, the first LNA-based in vitro diagnostic test for detecting the antibiotic resistant superbugs vancomycin-resistant Enterococci (VRE) and vancomycin-resistant Staphylococcus aureus (VRSA) in positive blood cultures and clinical isolates.
Read MoreThe FDA has cleared a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin, which is used to prevent potentially fatal clots in blood vessels.
Read MoreGene Express Inc, Toledo, Ohio, says its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study.
Read MoreThe US Department of Defense has awarded $5 million to a program that supports key research studies on lupus and lupus biomarkers.
Read MoreSept 24, 2007 VeriChip released a statement last week refuting claims that its implantable microchips are linked to cancer, offering a number of studies that it says support its position. VeriChip, which develops radio frequency identificati
Read More